In humans, many diseases are associated with alterations in gut microbiota, namely
increases or decreases in the abundance of specific bacterial groups. One example is the …

In recent years evidence has emerged that neurodegenerative diseases (NDs) are strongly
associated with the microbiome composition in the gut. Parkinson's disease (PD) is the most …

Aside from PD-L1 expression, biomarkers of response to immune checkpoint inhibitors (ICIs)
in non-small-cell lung cancer (NSCLC) are needed. In a previous retrospective analysis, we …

Akkermansia muciniphila and Faecalibacterium prausnitzii, cohabitants in the intestinal
mucosa, are considered members of a healthy microbiota and reduction of both species …

Background Impaired intestinal barrier structure and function have been validated as an
important pathogenic process in type 2 diabetes mellitus (T2DM). Gut dysbiosis is thought to …

Faecalibacterium is prevalent in the human gut and a promising microbe for the
development of next-generation probiotics (NGPs) or biotherapeutics. Analyzing reference …

Background There is a growing interest in using gut commensal bacteria as “next
generation” probiotics. However, this approach is still hampered by the fact that there are …

Introduction Emerging evidence suggests that the essence of life is the ecological balance of
the neural, endocrine, metabolic, microbial, and immune systems. Gut microbiota have been …

Background Viral metagenomic studies have suggested a role for bacteriophages in
intestinal dysbiosis associated with several human diseases. However, interpretation of viral …

Faecalibacterium prausnitzii is one of the most important butyrate-producing bacteria in the
human gut. Previous studies have suggested the presence of several phylogenetic groups …